The Complex Landscape Surrounding High-Impact Drugs & Workers' Comp
While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for potential benefits to injured workers, as they may provide relief that traditional therapies cannot.